Immutep (IMMP) Long-Term Investments (2011)

Immutep (IMMP) posted Long-Term Investments of $589348.1 for Q2 2011.

Immutep (IMMP) Long-Term Investments (2011) Analysis & Trends

Immutep's Long-Term Investments history runs 1 years deep, the most recent figure standing at $589348.1 for Q2 2011.

Quarterly Long-Term Investments changed N/A year-over-year to $589348.1 in Q2 2011, while the trailing twelve-month figure through Jun 2011 was $589348.1 (changed N/A YoY) and the FY2011 annual result came in at $548901.5, changed N/A from the prior year.
Long-Term Investments was $589348.1 for Q2 2011 at Immutep.
Across five years, Long-Term Investments topped out at $589348.1 in Q2 2011 and bottomed at $589348.1 in Q2 2011.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Long-Term Investments (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	505,194.89
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	5.75 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	9.79 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Immutep	567.77 Mn	567.77 Mn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2011	589,348.08